Codiak Biosciences

Codiak files for Chapter 11 bankruptcy as most executives head for the exit
Endpoints
Mon, 03/27/23 - 09:59 am
Codiak Biosciences
bankruptcy
Codiak gets $2.5M from CEPI to forge way out of pandemic, prep for disease X
Biopharma Reporter
Thu, 07/7/22 - 10:25 am
pan-coronavirus vaccine
vaccines
CEPI
Codiak Biosciences
Codiak lands on Wall Street in second shot at IPO, raises $83M
Endpoints
Thu, 10/15/20 - 10:59 am
Codiak Biosciences
IPOs
IPO Update: Codiak BioSciences Proposes IPO Terms
Seeking Alpha
Thu, 10/8/20 - 11:06 am
Codiak Biosciences
IPOs
exosomes
Codiak files for an IPO, again, this time shooting for a nine-digit raise
Endpoints
Thu, 09/10/20 - 10:49 am
Codiak Biosciences
IPOs
Sarepta expands gene therapy toolkit, bets $72.5M to hitch a ride on Codiak's exosome tech
Endpoints
Mon, 06/22/20 - 10:26 am
Sarepta Therapeutics
Codiak Biosciences
gene therapy
Codiak BioSciences collaborates with Ragon Institute to evaluate exoVACC vaccine platform in SARS-CoV-2 and HIV
Pharmaceutical Business Review
Wed, 06/3/20 - 10:27 am
Codiak Biosciences
COVID-19
Ragon Institute
vaccines
Another company took an old drug and jacked up the price. Now, biotech CEOs are throwing shade
MedCity News
Sun, 02/23/20 - 01:58 pm
Codiak Biosciences
Belcher Pharmaceuticals
FDA
505(b) pathway
Ablysinol
Codiak Biosciences Lines up for $86 Million IPO
BioSpace
Wed, 05/1/19 - 12:16 pm
Codiak Biosciences
IPOs
exosomes
Former Biogen R&D Chief Emerges at $80M Startup Pursuing Cancer, Alzheimer's
Forbes
Tue, 11/17/15 - 09:11 am
Biogen
R&D
Alzheimer's disease
Codiak Biosciences